SAB Biotherapeutics, Inc. (NASDAQ:SABSW) Short Interest Down 98.1% in October
SAB Biotherapeutics, Inc. (NASDAQ:SABSW – Get Free Report) saw a significant decline in short interest in October. As of October 31st, there was short interest totalling 100 shares, a decline of 98.1% from the October 15th total of 5,200 shares. Based on an average daily volume of 13,200 shares, the short-interest ratio is presently 0.0 […]
More Stories
Security National Financial (NASDAQ:SNFCA) Rating Increased to Strong-Buy at StockNews.com
StockNews.com upgraded shares of Security National Financial (NASDAQ:SNFCA – Free Report) from a hold rating to a strong-buy rating in...
Aptose Biosciences (NASDAQ:APTO) Now Covered by Analysts at StockNews.com
StockNews.com began coverage on shares of Aptose Biosciences (NASDAQ:APTO – Free Report) (TSE:APS) in a research report sent to investors...
IAC (NASDAQ:IAC) & Eventbrite (NYSE:EB) Head to Head Analysis
Eventbrite (NYSE:EB – Get Free Report) and IAC (NASDAQ:IAC – Get Free Report) are both computer and technology companies, but...
Haiti: Child recruitment by armed groups surges 70 per cent
The number of children being recruited into armed groups across Haiti has increased by 70 per cent over the past...
Reviewing FFBW (NASDAQ:FFBW) & Carver Bancorp (NASDAQ:CARV)
Profitability This table compares FFBW and Carver Bancorp’s net margins, return on equity and return on assets. Net Margins Return...
Valuence Merger Corp. I (VMCA) & Its Rivals Financial Review
Volatility and Risk Valuence Merger Corp. I has a beta of 0.01, indicating that its stock price is 99% less...